Lohoff, Falk W.
National Institutes of Health · National Institute on Alcohol Abuse and Alcoholism
14 papers on CoChatORCID 0000-0002-0480-7755
Most cited papers
- Verified
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
Psychiatric GWAS Consortium Bipolar Disorder Working Group, Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., Edenberg, H. J., Nurnberger, J. I., Rietschel, M., et al. (2011) · Nature Genetics
Bipolar Disorder and TreatmentGenetic Associations and Epidemiology
Cited by 1,344
- Verified
Overview of the Genetics of Major Depressive Disorder
Lohoff, F. W. (2010) · Current Psychiatry Reports
Genetic Associations and EpidemiologyTreatment of Major Depression
Cited by 498
- Verified
Genome-wide association study of bipolar disorder in European American and African American individuals
Smith, E. N., Bloss, C. S., Badner, J. A., Barrett, T., Belmonte, P. L., Berrettini, W., Byerley, W., Coryell, W., Craig, D., Edenberg, H. J., et al. (2009) · Molecular Psychiatry
Bipolar Disorder and TreatmentGenetic Associations and Epidemiology
Cited by 363
- Verified
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders: A Multivariable Mendelian Randomization Analysis
Rosoff, D. B., Smith, G. D., & Lohoff, F. W. (2021) · JAMA Psychiatry
Opioid Use Disorder TreatmentGenetic Associations and Epidemiology
Cited by 186
- Verified
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function
Rosoff, D. B., Bell, A. S., Jung, J., Wagner, J., Mavromatis, L. A., & Lohoff, F. W. (2022) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology
Cited by 126
- Verified
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
O’Connell, E. M., & Lohoff, F. W. (2020) · Frontiers in Neuroscience
Lipoproteins and Cardiovascular HealthAlzheimer's disease research and treatments
Cited by 93
- Verified
Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release
Rickels, K., Etemad, B., Khalid-Khan, S., Lohoff, F. W., Rynn, M. A., & Gallop, R. J. (2010) · Archives of General Psychiatry
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression
Cited by 63
- Verified
Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction
Clarke, T. ‐., Ambrose‐Lanci, L., Ferraro, T. N., Berrettini, W. H., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O’Brien, C. P., Oslin, D. W., & Lohoff, F. W. (2012) · Genes, Brain and Behavior
Neurotransmitter Receptor Influence on BehaviorGenetic Associations and Epidemiology
Cited by 55
- Verified
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
Bell, A. S., Wagner, J., Rosoff, D. B., & Lohoff, F. W. (2023) · Neuroscience & Biobehavioral Reviews
Lipoproteins and Cardiovascular HealthAlzheimer's disease research and treatments
Cited by 36
- Verified
PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
Lee, J. S., O’Connell, E. M., Pacher, P., & Lohoff, F. W. (2021) · Journal of Clinical Medicine
Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes
Cited by 31
- Verified
Imaging resilience and recovery in alcohol dependence
Charlet, K., Rosenthal, A., Lohoff, F. W., Heinz, A., & Beck, A. (2018) · Addiction
Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior
Cited by 29
- Verified
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury
Wagner, J., Park, L. M., Mukhopadhyay, P., Matyas, C., Trojnar, E., Damadzic, R., Jung, J., Bell, A. S., Mavromatis, L. A., Hamandi, A. M., et al. (2024) · Brain, Behavior, and Immunity
Neuroinflammation and Neurodegeneration MechanismsAlcohol Consumption and Health Effects
Cited by 26
- Verified
Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition?
Park, L. M., Pacher, P., & Lohoff, F. W. (2024) · ACS Chemical Neuroscience
Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments
Cited by 16
- Verified
Multiomic Mendelian Randomization Study Investigating the Impact of PCSK9 and HMGCR Inhibition on Type 2 Diabetes Across Five Populations
Rosoff, D. B., Wagner, J., Jung, J., Pacher, P., Christodoulides, C., Davey Smith, G., Ray, D., & Lohoff, F. W. (2025) · Diabetes
Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free